IMM.L
ImmuPharma Plc
Latest RNS
Powered by Vox Markets
- Immupharma PLC - Finals results for y/e 31 December 2021
- Immupharma PLC - UPDATE on LUPUZOR™ PROGRESS to PHASE 3 with AVION
- Immupharma PLC - UPDATE on P140 (LUPUZOR™) clinical progress
- Immupharma PLC - LUPUZOR UPDATE
- Immupharma PLC - TR-1: Notification of major holdings
- Immupharma PLC - TR-1: Notification of major holdings
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Subscriptions and Placing to raise £3.55 million
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - COLLABORATION WITH IMPERIAL COLLEGE LONDON
- Immupharma PLC - Corporate Update
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Euronext Delisting
- Immupharma PLC - Euronext Delisting
- Immupharma PLC - PROF. SYLVIANE MULLER AWARDED ‘LEGION D’HONNEUR’
- Immupharma PLC - Interim Results for the 6months ended 30 June 2021
- Immupharma PLC - Corporate Update
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Director/PDMR Shareholding
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Notification of Major Holdings
- Immupharma PLC - FDA approves the Lupzuor™ PK study
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Board Changes
- Immupharma PLC - Board Appointment
- Immupharma PLC - 2021 RESULT OF ANNUAL GENERAL MEETING -REPLACEMENT
- Immupharma PLC - 2021 RESULT OF ANNUAL GENERAL MEETING
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Update: Lupzuor™ PK study
- Immupharma PLC - Notice of AGM and posting of Report & Accounts
- Immupharma PLC - Director Retirement
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Final Results
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Update- scheduled Phase 3 trials in lupus patients
- Immupharma PLC - Appointment of Company Secretary
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - IMM TO PRESENT AT BIOTECH SHOWCASE DIGITAL 2021
- Immupharma PLC - Total Share Capital Notification
- Immupharma PLC - Grant of Share Options & PDMR dealing
- Immupharma PLC - Conversion of Convertible Security
- Immupharma PLC - Conversion of Convertible Security
- Immupharma PLC - Update : FDA confirms 4 Dec for Type ‘A’ meeting
- Immupharma PLC - Total Share Capital Notification - Replacement
- Immupharma PLC - Update on submission to the FDA
- Immupharma PLC - Total Share Capital Notification
- Immupharma PLC - Interim Results
- Immupharma PLC - Share Subscription into Incanthera plc
- Immupharma PLC - Repayment of Convertible Security
- Immupharma PLC - Update on submission to the FDA
- Immupharma PLC - Conversion of Convertible Security
- Immupharma PLC - Conversion of Convertible Security
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Director/PDMR Shareholding / TR -1
- Immupharma PLC - Placing - update; related party transaction)
- Immupharma PLC - Conversion of Convertible Security
- Immupharma PLC - Placing to raise £6.5 million
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - FDA submission for Special Protocol Assessment
- Immupharma PLC - 2020 AGM – ALL RESOLUTIONS PASSED
- Immupharma PLC - Total Share Capital Notification
- Immupharma PLC - TR-1 Notification of major holdings
- Immupharma PLC - STRAT. INVTS FROM 2 SPECIALIST US H'CARE INVESTORS
- Immupharma PLC - Change of Registered Office Address
- Immupharma PLC - Notification of Change of AGM Venue
- Immupharma PLC - Notice of AGM and posting of Report & Accounts
- Immupharma PLC - TR-1: Notification of major holdings
- Immupharma PLC - Efforts in fight vs Covid-19 with Lupuzor; Ureka
- Immupharma PLC - Audited Report & Accounts published on website
- Immupharma PLC - FINAL RESULTS FOR THE 12M ENDED 31/12/19
- Immupharma PLC - IMM live on Investor Meet Company platform 7 April
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - £1.5m Subscrip'n to fund R&D pipeline- replacement
- Immupharma PLC - £1.5m Subscription to fund R&D pipeline expansion
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Incanthera plc – Admission to trading on NEX
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Incanthera announces Rule 23 Notice re NEX listing
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Update on the Avion Agreement
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Admission today to trading on Euronext Growth
- Immupharma PLC - Publication of Information Note (Euronext Growth)
- Immupharma PLC - Dual Listing on Euronext Growth Brussels
- Immupharma PLC - Share Price Volatility
- Immupharma PLC - IMMUPHARMA TO PRESENT AT BIOTECH SHOWCASET 2020
- Immupharma PLC - TR-1: notification of major holdings
- Immupharma PLC - Licence Agreement for Lupuzor with Avion in US
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Interim Results Announcement
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - TR-1: notification of major holdings
- Immupharma PLC - TR-1: notification of major holdings
- Immupharma PLC - TR-1: notification of major holdings
- Immupharma PLC - Update on Lupuzor
- Immupharma PLC - 2019 Annual General Meeting
- Immupharma PLC - Subscription to raise £2.66 million
- Immupharma PLC - Notice of AGM and posting of Report & Accounts
- Immupharma PLC - FINAL RESULTS
- Immupharma PLC - Corporate Update - Replacement
- Immupharma PLC - Corporate Update - Replacement
- Immupharma PLC - Corporate Update
- Immupharma PLC - Update on Nucant Cancer Programme
- Immupharma PLC - Corporate Update
- Immupharma PLC - Technology review published-Nature Communications
- Immupharma PLC - Clinical Development Collaboration with Incanthera
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Appointment of Nominated Adviser
- Immupharma PLC - Update on Corporate Activities
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Nominated Adviser Status
- Immupharma PLC - Interim Results
- Immupharma PLC - Appointment of Joint Brokers
- Immupharma PLC - Corporate Update
- Immupharma PLC - Second Price Monitoring Extn
- Immupharma PLC - Price Monitoring Extension
- Immupharma PLC - Result of AGM
- Immupharma PLC - Results of CIDP Pre-Clinical Data
- Immupharma PLC - Notice of AGM & Posting of Annual Report
- Immupharma PLC - Final Results
- Immupharma PLC - Update on Pivotal Phase III Trial of Lupuzor
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Topline results of Lupuzor Pivotal Phase III Trial
- Immupharma PLC - Appointment of Joint Broker
- Immupharma PLC - Lupuzor Pivotal Phase III Study Update
- Immupharma PLC - AIM Notice (17)
- Immupharma PLC - Grant of Options
- Immupharma PLC - Last patient completes dosing in LupuzorT Trial
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Grant of Options
- Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
- Immupharma PLC - Holding(s) in Company
- Immupharma PLC - Completion of Lanstead Sharing Agreement
- Immupharma PLC - Interim Results
- Immupharma PLC - Preparation of Lupuzor'sT Regulatory Submissions
- Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
- Immupharma PLC - Notification of Interim Results
- Immupharma PLC - AIM Rule 17 Notice
- Immupharma PLC - Grant of Options
- Immupharma PLC - Result of AGM
- Immupharma PLC - Update on LupuzorT Pivotal Phase III Study
- Immupharma PLC - Annual Report & Notice of AGM
- Immupharma PLC - Final Results